https://c2n.com/news-releases daily 0.75 2026-03-19 https://c2n.com/news-releases/c2n-highlights-first-use-of-its-emtbr-tau243-plasma-assay-in-evokeevoke-phase-3-dataset-for-prediction-of-cognitive-and-functional-decline-in-patients-with-early-symptomatic-adnbsp monthly 0.5 2026-03-19 https://c2n.com/news-releases/c2n-diagnostics-enters-south-korean-market-through-partnership-withbeaubrain-healthcare-to-offer-precivity-portfolio-of-blood-tests-tohelp-doctors-diagnose-alzheimers-disease monthly 0.5 2026-03-11 https://c2n.com/news-releases/c2n-diagnostics-awarded-rigorous-new-york-state-department-of-health-permit-expanding-ability-to-provide-its-blood-tests-tohelp-diagnose-alzheimers-disease monthly 0.5 2025-11-24 https://c2n.com/news-releases/c2n-diagnostics-and-washu-medicine-teams-receive-prestigious-award-from-human-proteome-organization monthly 0.5 2025-11-13 https://c2n.com/news-releases/c2n-submits-us-fda-regulatory-filing-for-its-alzheimers-disease-blood-test monthly 0.5 2025-10-01 https://c2n.com/news-releases/new-research-reinforces-c2ns-precivityad2-blood-test-as-a-highly-accurate-tool-to-detect-brain-amyloid-pathology-in-symptomatic-patientsnbsp monthly 0.5 2025-09-25 https://c2n.com/news-releases/dynamic-growth-leads-c2n-diagnostics-to-expand-st-louis-headquarters-to-meet-global-need-for-answers-to-alzheimers-disease-nbsp monthly 0.5 2025-09-03 https://c2n.com/news-releases/c2n-diagnostics-expands-the-precivityad2-alzheimers-disease-blood-test-intended-use-to-patients-50-years-and-older monthly 0.5 2025-08-25 https://c2n.com/news-releases/c2n-announces-major-global-expansion-adds-six-new-international-partners monthly 0.5 2025-08-07 https://c2n.com/news-releases/c2n-diagnostics-expands-portfolio-of-blood-tests-for-clinical-researchers-studying-alzheimers-disease-and-related-dementiasnbsp monthly 0.5 2025-07-15 https://c2n.com/news-releases/samsung-invests-in-c2n-diagnosticsnbsp monthly 0.5 2025-03-13 https://c2n.com/news-releases/c2n-diagnostics-precivityad2-blood-test-receives-mhra-medical-device-certification-in-the-united-kingdomnbsp monthly 0.5 2025-02-24 https://c2n.com/news-releases/study-highlights-how-c2ns-precivityad2-blood-biomarker-test-use-improvesnbsp-clinical-decision-making-in-the-evaluation-for-alzheimers-disease-nbspnbsp monthly 0.5 2025-01-31 https://c2n.com/news-releases/first-canadian-clinic-to-offer-c2ns-precivityad2-blood-test-to-help-healthcare-providers-diagnose-alzheimers-disease-joining-global-community-in-embracing-breakthrough-technology monthly 0.5 2025-01-28 https://c2n.com/news-releases/c2n-diagnostics-partners-with-the-michael-j-fox-foundation-to-uncovernew-links-between-parkinsons-disease-lewy-body-dementia-andalzheimers-disease monthly 0.5 2025-01-15 https://c2n.com/news-releases/c2n-diagnostics-receives-15-million-program-related-investment-from-ghr-foundation-to-develop-tau-tangle-pathology-test-for-diagnosing-staging-alzheimers-disease monthly 0.5 2024-09-30 https://c2n.com/news-releases/c2n-receives-funding-from-diagnostics-accelerator-to-develop-a-decentralized-clinical-mass-spectrometry-solution-to-enable-high-performance-alzheimers-disease-testing-worldwide monthly 0.5 2024-09-25 https://c2n.com/news-releases/jama-publishes-landmark-clinical-study-showing-c2n-diagnostics-precivityad2-blood-test-markedly-improves-accuracy-of-ad-diagnosis-in-both-primary-care-and-specialized-memory-care monthly 0.5 2024-07-28 https://c2n.com/news-releases/c2n-diagnostics-says-fdas-approval-of-donanemab-highlights-its-role-in-helping-to-determine-alzheimers-disease-pathology monthly 0.5 2024-07-02 https://c2n.com/news-releases/c2ns-precivity-tests-are-now-offered-through-mayo-clinic-laboratoriesnbsphealthcare-providers-have-expanded-access-to-c2ns-blood-tests-tonbspbetter-identify-alzheimers-disease-pathologynbsp monthly 0.5 2024-06-27 https://c2n.com/news-releases/cn-diagnostics-expands-into-japan-through-mediford-corporation-partnership-with-precivity-blood-testing-foralzheimers-disease-and-brain-research-market monthly 0.5 2024-04-26 https://c2n.com/news-releases/study-finds-cn-diagnostics-precivityad-blood-test-provides-opportunities-for-robust-cost-savings-in-the-evaluation-of-patients-with-cognitive-impairment monthly 0.5 2024-04-01 https://c2n.com/news-releases/new-research-shows-the-precivityad2-blood-test-has-high-accuracy-compared-to-amyloid-pet-scans-in-individuals-with-cognitive-impairment monthly 0.5 2024-03-18 https://c2n.com/news-releases/cn-diagnostics-llc-announces-investment-from-eisai-inc monthly 0.5 2024-03-06 https://c2n.com/news-releases/researchers-identify-new-cost-savings-and-accuracy-of-cn-diagnostics-blood-tests-to-enable-healthcare-providers-to-better-identify-alzheimers-disease monthly 0.5 2023-11-16 https://c2n.com/news-releases/new-research-shows-new-research-shows-high-accuracy-of-precivity-blood-biomarkers-in-the-evaluation-of-brain-amyloid-inpre-clinical-alzheimers-disease monthly 0.5 2023-11-08 https://c2n.com/news-releases/cn-diagnostics-introduces-next-generation-fluid-biomarker-to-the-field-of-alzheimers-disease-test-to-help-researchers-track-neurofibrillary-tau-tangle-pathology monthly 0.5 2023-10-25 https://c2n.com/news-releases/on-world-alzheimers-day-cn-diagnostics-precivityad2-blood-test-expands-reach monthly 0.5 2023-09-21 https://c2n.com/news-releases/cnnbspdiagnostics-releases-the-precivityad2-blood-test-for-clinical-care monthly 0.5 2023-08-29 https://c2n.com/news-releases/evidence-shows-healthcare-providers-use-cn-diagnostics-precivityad-blood-test-to-help-affirm-alzheimers-disease-diagnosis-andchange-drug-treatment-decisionsnbsp-nbsp monthly 0.5 2023-08-08 https://c2n.com/news-releases/alzheimers-disease-community-benefits-as-c2n-diagnostics-precivity-related-blood-biomarkers-demonstrate-robust-effectiveness-set-new-performance-standardnbsp monthly 0.5 2023-08-02 https://c2n.com/news-releases/c2n-diagnostics-used-in-clinical-trials-for-leqembi-for-alzheimers-disease-treatment-is-poised-to-support-medical-community-in-next-steps monthly 0.5 2023-08-08 https://c2n.com/news-releases/cn-diagnostics-building-on-recent-achievements-bolsters-executive-team-as-it-prepares-for-commercial-expansion-nbspnbsp monthly 0.5 2023-04-24 https://c2n.com/news-releases/cn-diagnostics-precivity-related-blood-biomarkers-shown-to-improve-diagnostic-accuracy-and-future-risk-prediction-of-alzheimers-disease-in-two-studies-presented-at-adpd-2023 monthly 0.5 2023-04-04 https://c2n.com/news-releases/cns-precivityad-blood-test-which-identifies-amyloid-pathology-as-an-aid-to-alzheimers-disease-diagnosis-further-demonstrates-its-high-accuracy-in-newly-published-research monthly 0.5 2023-03-29 https://c2n.com/news-releases/cn-diagnostics-announces-follow-on-investment-from-ghr-foundation-as-it-builds-on-success-in-novel-diagnostics-to-aid-in-alzheimers-disease-fight monthly 0.5 2023-02-16 https://c2n.com/news-releases/c2n-diagnostics-precivityad-and-precivityad2-blood-tests-at-ctad-2022highlight-the-potential-and-use-of-blood-based-biomarkersin-the-diagnosis-of-alzheimers-disease monthly 0.5 2023-02-01 https://c2n.com/news-releases/c2n-diagnostics-introduces-the-precivityad2-blood-testnext-generation-blood-test-aims-to-establish-new-standard-in-alzheimers-disease-diagnosis-with-combined-measures-of-amyloid-beta-and-tau-protein monthly 0.5 2022-11-29 https://c2n.com/news-releases/international-researchers-poised-to-learn-new-insights-about-c2n-diagnostics-blood-test-innovations-at-clinical-trials-on-alzheimers-disease-conference monthly 0.5 2022-11-17 https://c2n.com/news-releases/cn-diagnostics-marks-two-years-of-precivityad-blood-test-accomplishments monthly 0.5 2022-10-21 https://c2n.com/news-releases/cn-diagnostics-partners-with-grupo-fleury-to-bring-pioneering-blood-tests-to-brazil-for-advancing-brain-health monthly 0.5 2022-09-21 https://c2n.com/news-releases/independent-research-finds-underlying-method-for-c2ns-p-tau217-ratioblood-test-outperforms-other-tau-blood-tests-used-for-alzheimers-diagnoses monthly 0.5 2022-09-14 https://c2n.com/news-releases/c2n-diagnostics-and-healius-ltd-announce-partnership-to-bring-precivityad-and-related-brain-health-biomarkers-to-patients-in-australia monthly 0.5 2022-08-30 https://c2n.com/news-releases/c2n-and-eisai-collaborate-to-build-awareness-and-real-world-evidence-for-blood-based-assays-for-cognitive-impairment-in-clinical-practice-outside-of-clinical-trial-settings monthly 0.5 2022-08-23 https://c2n.com/news-releases/e0d71z6sgzfa931ht4kjryyxt9ps6l monthly 0.5 2022-07-31 https://c2n.com/news-releases/c2n-diagnostics-introduces-p-tau-multi-analyte-assay-for-research-use-only-to-advance-alzheimers-disease-and-brain-health-field monthly 0.5 2022-05-18 https://c2n.com/news-releases/jama-network-open-publishes-analysis-of-results-of-two-independent-studies-demonstrating-the-high-diagnostic-performance-of-the-precivityad-blood-test-for-alzheimers-disease monthly 0.5 2022-04-21 https://c2n.com/news-releases/c2n-achieves-a-hrefx-webdoc33f08c7f-651b-4a92-974a-04c722961c45-targetblankiso-134852016-certificationa-latest-development-for-leader-in-brain-health-sector monthly 0.5 2022-02-22 https://c2n.com/news-releases/c2n-begins-new-year-with-cap-accreditation-award-the-highest-standard-in-laboratory-practices monthly 0.5 2022-01-04 https://c2n.com/news-releases/major-research-findings-highlight-effectiveness-of-the-precivityad-blood-test-that-clinicians-use-to-aid-in-alzheimers-disease-diagnosis monthly 0.5 2021-11-12 https://c2n.com/news-releases/cn-opens-state-of-the-art-clia-lab-in-st-louis-as-alzheimers-disease-blood-diagnostic-test-bests-others-in-independent-comparison-studies-published-in-jama-neurology monthly 0.5 2021-09-21 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/1632261776754-Q1TC1J90XIM73TWQ1WVU/4340+Duncan+Ave.jpg News Releases - C₂N Opens State-of-the-Art CLIA Lab in St. Louis as Alzheimer’s Disease Blood Diagnostic Test Bests Others in Independent Comparison Studies Published in JAMA Neurology - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://c2n.com/news-releases/two-research-studies-bolster-method-that-cns-precivityad-blood-test-uses-to-aid-clinicians-in-alzheimers-disease-diagnoses monthly 0.5 2021-08-16 https://c2n.com/news-releases/cn-diagnostics-statement-on-fda-accelerated-approval-of-aducanumab-foralzheimers-treatment monthly 0.5 2022-01-21 https://c2n.com/news-releases/y5xiklh5uuyz9anu2hqugqui8be5cl monthly 0.5 2021-06-02 https://c2n.com/news-releases/2021/05/05/2021-5-5-peer-reviewed-journal-publishes-precivityad-blood-test-research-confirming-its-role-in-assisting-clinicians-in-alzheimers-diagnosis monthly 0.5 2021-05-19 https://c2n.com/news-releases/2021/04/29/2021-5-3-rhode-island-patients-now-have-access-to-breakthrough-alzheimers-diagnostic-blood-test monthly 0.5 2021-05-17 https://c2n.com/news-releases/2021/03/08/2021-3-8-c2n-diagnostics-boosted-by-growth-from-the-precivityad-blood-test-named-by-fierce-medtech-as-a-fierce-15 monthly 0.5 2021-05-25 https://c2n.com/news-releases/2020/10/29/2020-10-28-alzheimers-breakthrough-cn-first-to-offer-a-widely-accessible-blood-test monthly 0.5 2021-05-17 https://c2n.com/news-releases/2020/07/28/2020-7-28-identification-of-p-tau217-in-blood-samples-offers-early-detection-of-alzheimers-disease-and-builds-interest-in-c2n-intellectual-property monthly 0.5 2021-05-25 https://c2n.com/news-releases/2020/05/14/2020-5-14-c2n-diagnostics-receives-20m-program-related-investment-from-ghr-foundation-to-bring-alzheimers-blood-test-to-the-clinic monthly 0.5 2021-05-25 https://c2n.com/news-releases/2019/12/09/2019-12-9-c2n-diagnostics-reports-high-accuracy-of-aptus-a-blood-test-for-detecting-early-alzheimers-disease-pathology monthly 0.5 2021-05-25 https://c2n.com/news-releases/2019/12/02/2019-12-2-c2n-diagnostics-to-report-results-of-aptus-a-blood-test-for-alzheimers-disease-brain-pathology monthly 0.5 2021-05-25 https://c2n.com/news-releases/2019/01/29/2019-1-24-c2n-diagnostics-receives-breakthrough-device-designation-from-us-fda-for-blood-test-to-screen-for-alzheimers-disease-risk monthly 0.5 2021-05-25 https://c2n.com/news-releases/2017/01/25/2017-01-abbvie-initiates-phase-2-clinical-trial-programs-for-abbv-8e12-an-investigational-anti-tau-antibody-in-early-alzheimers-disease-and-progressive-supranuclear-palsy monthly 0.5 2021-05-17 https://c2n.com/news-releases/2016/12/09/2016-12-c2n-diagnostics-reports-phase-1-study-results-of-c2n-8e12-abbv-8e12-anti-tau-antibody-in-subjects-with-progressive-supranuclear-palsy monthly 0.5 2021-05-25 https://c2n.com/news-releases/2016/10/13/2016-10-c2n-diagnostics-completes-phase-1-clinical-study-of-c2n-8e12-abbv-8e12-among-individuals-with-progressive-supranuclear-palsy monthly 0.5 2021-05-25 https://c2n.com/news-releases/2015/10/13/2015-10-curepsp-forms-subsidiary-to-promote-clinical-trials monthly 0.5 2021-05-17 https://c2n.com/news-releases/2015/08/07/2015-08-c2n-and-abbvie-announce-fda-orphan-drug-designation-of-c2n-8e12-abbv-8e12-for-the-treatment-of-progressive-supranuclear-palsy monthly 0.5 2021-05-25 https://c2n.com/news-releases/2015/03/19/2015-03-abbvie-and-c2n-enter-into-a-worldwide-license-agreement-for-alzheimers-disease-therapy monthly 0.5 2021-05-25 https://c2n.com/news-releases/2014/07/14/2014-07-c2n-expands-partnership-with-washington-u-to-commercialize-blood-test-for-detection-of-early-ad monthly 0.5 2021-05-25 https://c2n.com/news-releases/2013/09/19/2013-09-c2n-diagnostics-makes-three-new-hires-to-speed-commercialization-of-diagnostics-and-theranostics monthly 0.5 2021-05-25 https://c2n.com/news-releases/2013/07/12/2013-07-c2n-diagnostics-announces-collaborative-research-agreement-with-cambridge-isotopes monthly 0.5 2021-05-25 https://c2n.com/news-releases/2013/06/14/2013-06-silk-abeta-study-detects-early-changes-in-brain-amyloid-pathology monthly 0.5 2021-05-17 https://c2n.com/news-releases/2013/01/02/2013-01-pre-competitive-consortium-to-develop-standardize-and-validate-preclinical-aged-canine-model-of-ad monthly 0.5 2021-05-17 https://c2n.com/news-releases/2012/08/30/2012-08-newly-study-in-pnas-links-ldl-receptor-to-abeta-brain-clearance monthly 0.5 2021-05-17 https://c2n.com/news-releases/2012/08/07/2012-08-c2n-diagnostics-receives-sbir-award-to-study-novel-tau-biomarkers-in-alzheimers-disease monthly 0.5 2025-12-17 https://c2n.com/news-releases/2010/03/18/2010-03-c2n-diagnostics-announces-key-new-hire-and-1m-grant-from-anonymous-donor-to-support-alzheimers-biomarkers-and-diagnostics-programs monthly 0.5 2021-05-25 https://c2n.com/news-releases/2009/12/17/2009-12-c2n-diagnostics-awarded-fast-track-sbir-by-nianih monthly 0.5 2021-05-25 https://c2n.com/news-releases/2009/11/12/2009-11-c2n-diagnostics-announces-successful-completion-of-milestones-under-300000-alzheimers-drug-discovery-foundation-award monthly 0.5 2021-05-25 https://c2n.com/news-releases/2008/06/02/2008-06-c2n-diagnostics-launches-alzheimers-research-tool monthly 0.5 2021-05-25 https://c2n.com/news-releases/category/News+Releases monthly 0.5 https://c2n.com/news-releases/tag/APTUS%E2%84%A2 monthly 0.5 https://c2n.com/media-coverage daily 0.75 2026-03-24 https://c2n.com/media-coverage/alzforum-not-if-but-when-blood-p-tau217-clock-tells-time-of-ad-onset monthly 0.5 2026-03-02 https://c2n.com/media-coverage/the-flow-space-how-biomarkers-and-blood-testing-are-transforming-early-alzheimers-detection monthly 0.5 2026-01-05 https://c2n.com/media-coverage/360dx-c2n-diagnostics-receives-lab-permit-from-ny-state monthly 0.5 2025-11-26 https://c2n.com/media-coverage/st-louis-magazine-c2ns-expansion-into-former-goodwill-building-boosts-st-louis-bioscience-startup-ecosystem monthly 0.5 2025-09-04 https://c2n.com/media-coverage/patient-care-novel-plasma-assay-that-selectively-detect-tau-characteristics-will-refine-clinical-study-of-alzheimers-disease monthly 0.5 2025-08-18 https://c2n.com/media-coverage/360dx-c2n-diagnostics-inks-asia-distribution-deal-for-alzheimers-test-with-archerfish-precision-dx monthly 0.5 2025-08-18 https://c2n.com/media-coverage/360dx-c2n-diagnostics-c2n-emtbr-tau243-and-c2n-p-tau-maa-tests monthly 0.5 2025-08-18 https://c2n.com/media-coverage/pharmaexcom-the-fight-for-alzheimers-research-funding monthly 0.5 2025-08-18 https://c2n.com/media-coverage/scitechdaily-new-blood-test-detects-alzheimers-and-tracks-its-progression-with-92-accuracy monthly 0.5 2025-05-13 https://c2n.com/media-coverage/samsung-backs-alzheimers-blood-test-developer-c2n-diagnostics-with-10m monthly 0.5 2025-05-13 https://c2n.com/media-coverage/healio-blood-test-may-improve-decision-making-in-alzheimers-disease monthly 0.5 2025-02-18 https://c2n.com/media-coverage/philanthropy-news-digest-mjff-awards-15-million-to-c2n-diagnostics-for-neurological-research monthly 0.5 2025-01-24 https://c2n.com/media-coverage/washington-post-alzheimers-patients-and-their-families-hear-a-new-word-progress monthly 0.5 2024-10-18 https://c2n.com/media-coverage/medical-device-network-c2n-receives-funding-for-alzheimers-disease-testing-platform monthly 0.5 2024-09-30 https://c2n.com/media-coverage/nih-research-matters-accurate-blood-test-for-alzheimers-disease monthly 0.5 2024-08-15 https://c2n.com/media-coverage/usa-today-how-a-new-blood-test-technology-could-change-alzheimers-treatment-forever monthly 0.5 2024-08-12 https://c2n.com/media-coverage/st-louis-post-dispatch-a-st-louis-firm-races-to-diagnose-alzheimers-faster monthly 0.5 2024-08-12 https://c2n.com/media-coverage/the-clinical-trial-vanguard-c2n-diagnostics-partners-with-mediford-for-precivitytm-alzheimers-blood-test-expansion-in-japan monthly 0.5 2024-05-02 https://c2n.com/media-coverage/fierce-biotech-eisai-to-drop-up-to-15m-on-c2n-diagnostics-to-boost-the-reach-of-alzheimers-disease-blood-tests monthly 0.5 2024-03-07 https://c2n.com/media-coverage/fierce-biotech-study-shows-a-front-line-alzheimers-blood-test-could-be-as-accurate-as-spinal-fluid-exams monthly 0.5 2024-03-02 https://c2n.com/media-coverage/360dx-alzheimers-biomarker-research-pushing-plasma-p-tau217-to-the-fore monthly 0.5 2024-02-13 https://c2n.com/media-coverage/alzforum-ad-blood-tests-are-here-now-lets-grapple-with-how-to-use-them monthly 0.5 2024-02-08 https://c2n.com/media-coverage/npr-blood-tests-can-help-diagnose-alzheimers-if-theyre-accurate-enough-not-all-are monthly 0.5 2024-01-12 https://c2n.com/media-coverage/medical-device-network-c2ns-precivity-blood-biomarker-shows-promise-in-alzheimers-screening monthly 0.5 2024-01-12 https://c2n.com/media-coverage/medscape-novel-tau-blood-biomarker-shows-promise monthly 0.5 2024-01-12 https://c2n.com/media-coverage/proactive-biovie-says-blinded-data-points-to-hopeful-alzheimers-treatment-potential monthly 0.5 2024-01-12 https://c2n.com/media-coverage/genomeweb-c2n-diagnostics-mtbr-tau monthly 0.5 2024-01-12 https://c2n.com/media-coverage/healio-participation-in-digital-cognitive-test-biomarker-assays-linked-to-ad-study-enrollment monthly 0.5 2024-01-12 https://c2n.com/media-coverage/fierce-biotech-cn-diagnostics-launches-revamped-alzheimers-blood-test monthly 0.5 2023-08-24 https://c2n.com/media-coverage/c2n-diagnostics-launches-new-precivityad2-blood-test monthly 0.5 2023-08-23 https://c2n.com/media-coverage/alzheimers-news-today-precivityad-test-for-alzheimers-guided-clinical-decision-making monthly 0.5 2023-08-14 https://c2n.com/media-coverage/being-patient-cns-alzheimers-blood-test-in-phils-journal monthly 0.5 2023-08-10 https://c2n.com/media-coverage/medpage-today-alzheimers-blood-tests-may-improve-primary-care-diagnoses monthly 0.5 2023-08-02 https://c2n.com/media-coverage/st-louis-business-journal-award monthly 0.5 2023-08-02 https://c2n.com/media-coverage/stat-we-finally-have-new-alzheimers-drugs-how-do-we-decide-who-gets-them monthly 0.5 2023-08-02 https://c2n.com/media-coverage/wall-street-journal-new-blood-tests-offer-possibly-early-detection-of-cancer-and-alzheimers monthly 0.5 2023-08-02 https://c2n.com/media-coverage/fierce-biotech-c2ns-amyloid-and-tau-detecting-alzheimers-blood-test-outperforms-other-screening-tests-in-two-studies monthly 0.5 2023-08-02 https://c2n.com/media-coverage/lab-pulse-c2n-diagnostics-announces-study-confirming-accuracy-of-test-for-alzheimers-diagnosis monthly 0.5 2023-08-02 https://c2n.com/media-coverage/is-it-alzheimers-families-want-to-know-and-blood-tests-may-offer-answers monthly 0.5 2023-08-02 https://c2n.com/media-coverage/a-new-era-of-diagnosis-for-alzheimers-disease-scientists-study-blood-tests-for-dementia monthly 0.5 2023-08-02 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/1651242284420-AK9G04ROKN44R5MAPV5X/USATSI_18162637.jpg Media Coverage - USA Today: A new era of diagnosis for Alzheimer's disease': Scientists study blood tests for dementia https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/1651242286543-2VREG2H7JRRVHKFRANWL/USATSI_18162629.jpg Media Coverage - USA Today: A new era of diagnosis for Alzheimer's disease': Scientists study blood tests for dementia https://c2n.com/media-coverage/blood-tests-could-help-screen-anticipated-flood-of-patients-seeking-new-alzheimers-drug monthly 0.5 2023-08-02 https://c2n.com/media-coverage/aduhelm-approval-amplifies-amyloid-assays monthly 0.5 2023-08-02 https://c2n.com/media-coverage/c2n-building-case-for-alzheimers-dx-as-aducanumab-approval-promises-to-impact-testing-space monthly 0.5 2023-08-02 https://c2n.com/media-coverage/bioworld-medtech-article-approval-of-aducanumab-paves-way-for-alzheimers-blood-tests monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2021/02/15/2021-2-18-c2n-diagnostics-has-brought-its-alzheimers-blood-test-to-market-now-it-wants-to-expand-in-st-louis-and-beyond monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2021/02/07/2021-2-18-the-other-pandemicnbsp-what-to-do-about-the-coming-alzheimers-crisis monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2021/02/04/2021-2-18-detecting-alzheimers-gets-easier-with-a-simple-blood-test monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2021/01/28/2021-2-18-blood-based-diagnostics-will-be-critical-to-a-comprehensive-national-alzheimers-response monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2021/01/06/2021-1-8-alzheimers-blood-tests-big-breakthroughs-in-2020 monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2020/12/27/2021-1-8-covid-19-wasnt-the-only-medical-story-this-year-heres-what-you-missed-in-2020 monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2020/12/23/2021-1-8-the-biggest-science-news-in-2020 monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2020/12/09/2020-12-8-precivityad-blood-tests-reach-expands-to-europe-and-california-following-initial-launch-test-detects-alzheimers-disease-pathology monthly 0.5 2021-05-25 https://c2n.com/media-coverage/2020/12/02/2020-12-1-first-blood-test-to-help-diagnose-alzheimers-goes-on-sale monthly 0.5 2020-12-02 https://c2n.com/media-coverage/2020/11/17/2020-11-17-first-alzheimers-blood-test-rolled-out-for-clinical-use-in-us monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2020/11/17/2020-11-17-the-rising-tide-of-scientific-innovation-biotech-in-2020-and-beyond monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2020/11/02/2020-12-14-first-alzheimers-blood-test-rolled-out-for-clinical-use-in-us monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2020/11/02/2020-12-14-the-rising-tide-of-scientific-innovation-biotech-in-2020-and-beyond monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2020/09/23/2020-9-23-d7bozjxs1ulvg9ujhk5g7wu2g181rk monthly 0.5 2021-05-25 https://c2n.com/media-coverage/2017/07/31/2017-07-blood-test-for-identifying-patients-with-alzheimers-disease monthly 0.5 2017-07-31 https://c2n.com/media-coverage/2017/05/05/2017-05-nih-director-highlights-tau-technology monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2017/04/19/2017-04-antibody-helps-detect-protein-implicated-in-alzheimers-other-diseases monthly 0.5 2017-04-19 https://c2n.com/media-coverage/2015/02/14/2015-02-c2n-diagnostics-plasma-based-biomarker-test-covered-by-medtech-insight monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2013/09/19/2013-09-c2n-diagnostics-makes-three-new-hires-to-speed-commercialization-of-diagnostics-and-theranostics monthly 0.5 2021-05-25 https://c2n.com/media-coverage/2013/01/14/2013-01-c2n-diagnostics-mentioned-on-alzforum monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2011/05/06/2011-05-c2n-tracking-technology-finds-alzheimers-faster monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2011/04/01/2011-04-a-recent-media-perspective-on-c2n-diagnostics monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2011/04/01/2011-04-c2n-diagnostics-probing-the-markers-of-disease monthly 0.5 2021-05-25 https://c2n.com/media-coverage/2010/12/10/2010-12-silk-ab-assay-provides-new-insights-into-the-potential-origins-of-alzheimers-disease monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2010/04/21/2010-04-cutting-health-cost-helps-new-ideas-sell monthly 0.5 2023-08-02 https://c2n.com/media-coverage/2009/06/30/2009-06-david-holtzman-attacking-alzheimers-with-a-new-test-for-amyloid-beta monthly 0.5 2009-06-30 https://c2n.com/media-coverage/2009/04/10/2009-04-washington-university-neurologists-create-alzheimers-drug-test monthly 0.5 2023-08-02 https://c2n.com/media-coverage/category/Media+Coverage monthly 0.5 https://c2n.com/media-coverage/category/Press+Releases monthly 0.5 https://c2n.com/media-coverage/tag/alzheimer%27s+disease monthly 0.5 https://c2n.com/media-coverage/tag/antibody monthly 0.5 https://c2n.com/media-coverage/tag/tau monthly 0.5 https://c2n.com/newsletters daily 0.75 2025-11-20 https://c2n.com/newsletters/ctad-2025 monthly 0.5 2025-11-20 https://c2n.com/newsletters/c2n-makes-many-moves-as-it-advances-science monthly 0.5 2025-11-05 https://c2n.com/newsletters/aaic-2025 monthly 0.5 2025-07-23 https://c2n.com/newsletters/c2n-at-adpd-2025-in-vienna monthly 0.5 2025-03-18 https://c2n.com/newsletters/c2n-year-in-review monthly 0.5 2025-01-15 https://c2n.com/newsletters/c2n-at-ctad-2024-in-madrid monthly 0.5 2024-10-22 https://c2n.com/newsletters/jama-published-landmark-clinical-study-on-alzheimers-disease-diagnosis-using-the-precivityad2-blood-test monthly 0.5 2024-09-04 https://c2n.com/newsletters/c2n-at-aaic-in-philadelphia-july-28aug-1 monthly 0.5 2024-07-16 https://c2n.com/newsletters/join-our-cn-diagnostics-team-at-the-16th-clinical-trials-on-alzheimers-disease-ctad-october-24-27-in-boston monthly 0.5 2023-10-18 https://c2n.com/newsletters/join-our-c2n-diagnostics-team-at-the-15th-clinical-trials-on-alzheimers-disease-ctad-in-san-francisco-november-29-december-2 monthly 0.5 2022-11-17 https://c2n.com/newsletters/cn-diagnostics-marks-two-years-of-precivityad-blood-test-accomplishments monthly 0.5 2022-10-21 https://c2n.com/newsletters/wan3tx6jy7hr69ra35zzmtea8r0wip monthly 0.5 2021-05-28 https://c2n.com/newsletters/hadz2bdj3wd7xsmn66uy6bjazyep29 monthly 0.5 2021-05-28 https://c2n.com/webinars daily 0.75 2024-09-06 https://c2n.com/webinars/blog-post-title-two-7gwh8-lexaw-sghg4 monthly 0.5 2026-02-04 https://c2n.com/webinars/blog-post-title-two-7gwh8-lexaw monthly 0.5 2026-02-04 https://c2n.com/webinars/blog-post-title-one-m2jyx monthly 0.5 2024-04-08 https://c2n.com/webinars/blog-post-title-two-7gwh8 monthly 0.5 2024-04-03 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/553670d3-7cfa-445d-bfcf-ab4821216dd0/Holtzman-251x360.jpg Webinars - Diagnostic Tools &amp; The New Blood Test</a> - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/eb27906e-3f98-4f83-b5f8-de7e14bd6f58/Smith-251x360.jpg Webinars - Diagnostic Tools &amp; The New Blood Test</a> - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://c2n.com/webinars/blog-post-title-three-k9z9a monthly 0.5 2023-10-05 https://c2n.com/home daily 1.0 2026-03-11 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/c5b90866-602e-4d38-8d95-0250d7589d41/Precivity_TM_Color_Reverse.png Home https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/11a43cc9-1065-4f17-b918-6aa66b9f87c4/certification_logos_20220301_BW_invert.png Home https://c2n.com/clinical-diagnostics daily 0.75 2025-08-27 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/5348095f-a4f2-46eb-a296-45c36e24738a/Precivity_TM_Color_Positive.png Clinical Diagnostics - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/61eaee97-2dff-42b9-88a2-0f9760fb4e59/CAP-accredited-logo_1.png Clinical Diagnostics - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/a8d8d7c4-1268-45d9-bfb7-9c5fc7662062/ISO-134852016.png Clinical Diagnostics - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/42af943d-7637-4766-b820-d9edcfd240ab/clia-logo.png Clinical Diagnostics - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/1621977437411-MTOWDRRCLJGXEX2CRCB9/1200px-Conformite%CC%81_Europe%CC%81enne_%28logo%29.svg.png Clinical Diagnostics - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://c2n.com/bioanalytical-services daily 0.75 2025-06-25 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/bfb10180-b79c-4c67-b913-f7f6d1b9c10f/bio-services-charts-1.png https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/76eb98f2-a495-4a61-82b0-96439de63644/bio-services-charts-2.png https://c2n.com/science daily 0.75 2025-06-23 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/1617661283019-OTWACOGNVYYANWNCJ6ND/icon4.png Science https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/1617661403143-JJG56Q94ZP08PLIGI72K/icon1.png Science https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/1617661423166-SCFU83C068BB8OS2KI2G/icon2.png Science https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/1617661498779-8JA8XHZ776U5HHSILUW6/icon3.png Science https://c2n.com/covid19-message daily 0.75 2021-05-28 https://c2n.com/hipaa-policy daily 0.75 2021-06-01 https://c2n.com/terms-of-use daily 0.75 2021-06-01 https://c2n.com/privacy-policy daily 0.75 2021-06-01 https://c2n.com/contact daily 0.75 2025-10-08 https://c2n.com/careers daily 0.75 2025-06-23 https://c2n.com/publications-clinical-use daily 0.75 2025-10-14 https://c2n.com/publications-research-trials daily 0.75 2025-07-25 https://c2n.com/our-team daily 0.75 2026-03-12 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/06a9cf42-6e7f-48d6-95b7-57b12dda4a8c/Joel%2BBraunstein.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/060ff332-0dbd-4e6c-b1eb-e3562f233fd5/Ilana+Fogleman+Dec+2023+-+cropped.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/b86dc001-5c40-4d60-99d4-8300a8b38bf1/Micah+Onixt+Dec+2023+-+cropped.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/64f7ffab-77db-47f7-a364-c3a65ed8b430/rahul-chaudhary.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/326a0afd-e8d8-448a-a1f9-3f8b909e3dce/Philip-Verghese-Dec-2023---cropped.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/cbe5dd9c-a889-4916-b4f5-8e3d4ca32470/Tim+West+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/dd46ee50-bb2f-45e0-959d-7b28f7975c59/Patricia+DeSimone+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/3f765dd7-6a90-4b53-aa0d-b1df0225f6c0/Tim%2BReilly.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/e2398b5a-53c2-431d-9700-7c6b736dd601/Justine+Coppinger+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/92f404e4-01d4-46f7-ba57-183a86d2285b/Chris%2BRathermel.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/0c7fb96f-ae3d-40cf-aed1-79abd7b4e42b/Glenn%2BGeorge.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/5facf883-a287-4ce7-9b82-9755240d2aa8/Joni+Henderson+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/bb273de9-7e24-4fa4-9065-b9184f09783b/Venky+Venkatesh+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/51a164f0-23fb-488c-b39a-6383572c11ce/Mark+Monane+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/e50fea21-f440-468e-be18-03958cfbb6d6/Daniel+Connell+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/d8662749-83a0-4fde-a546-f53eb286b103/Kris+Kirmess+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/597d8711-15c0-435b-ad83-012424e878cb/Matt+Meyer+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/363aa6a4-ca1b-4c98-a441-22f5befe84f2/Catherine+Regni+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/0ce8fbb2-946a-4c79-aaf1-aabe486ba55e/Brianne%2BPeters.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/d5b49faa-086e-4fc2-810b-bc6e8f28a7a2/wave_with_logo_headshot_placeholder.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/c2a9f9c7-f230-4849-8440-299e9b2f4767/Rachel+Resnick+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/4b02e189-e103-4c15-94b3-c8ef5561e034/Mary+Holbausch+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/7260b267-4b81-40f3-a8e7-a4c23ece6877/Scott+Hapstrite+Dec+2023.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/8752d3de-e85d-4d07-bad4-aea7cb5115e4/Erin+Smith.jpg Our Team - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://c2n.com/board daily 0.75 2025-10-13 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/06a9cf42-6e7f-48d6-95b7-57b12dda4a8c/Joel%2BBraunstein.jpg https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/83577f98-4362-4c7f-8801-ba60abba9f10/Daivd+Holtzman+Dec+2023.jpg https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/03461d70-93d6-483b-9315-7d074e595853/Randy+Bateman+Dec+2023.jpg https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/e71c55ab-aec1-494a-b551-cf88a4719f3a/Michael+Goldblatt+Dec+2023.jpg https://c2n.com/videos daily 0.75 2025-03-12 https://c2n.com/frequently-asked-questions daily 0.75 2025-03-10 https://c2n.com/international daily 0.75 2026-01-10 https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/0268e1ac-9ffc-40dc-ad12-6a9f15561349/MC_SUBRANDS_LABORATORIES_BLACK_RGB%5B45%5D.jpg https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/4b8365bd-c4e8-424b-940c-e286c91d2707/Healius_Logo_Primary_Watermelon%2BDarkBlue_WEB+%282%29%5B29%5D.jpg https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/bce2d095-cce4-446a-a135-2b24fd5347bf/grupo_fleury-logo-EDIT.png https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/448f230f-c98d-4eb1-9758-f12bc27d1bb9/Toronto-Memory-Program-Revised-Logo_FINAL-%28Dec-2012%29.png https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/2ce6f40e-3502-45db-9f33-fa78ced584cb/Codex+LOGO_horizontal-cs6+%28black+logo%29.png https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/9717944d-7b83-4d24-a8da-907de26946b7/DR+DANGS+LAB+LOGO+03+EDIT.png https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/d52699bb-e7c7-4ec6-aadc-7fedae133032/MedicalLink_logo_RGB-JPG-01%5B3%5D.jpg https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/6ce0ad40-f0da-48f7-9fe5-669f3954ddce/BeauBrain_CI_934x334.png https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/9d46a48d-a907-4b7e-b0ab-c43fb08c88f3/ML_completo-EDIT.png https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/c97a06c9-394c-441d-918c-013d65233817/Accuserv.png https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/956f0b3c-aa40-4a18-84d5-2837c62e035f/Archerfish-Brandmark-2025_Full-Colour_500px%5B90%5D-EDIT.png https://images.squarespace-cdn.com/content/v1/6051102c2fb3bb4596ed2368/6a9c3aca-00b1-41c7-9a7c-8e12f65a133b/veritas-h-EDIT.jpg https://c2n.com/california-declaration-of-compliance daily 0.75 2026-03-12